MedDRA stands for Medical Dictionary for Regulatory Activities. It is a standardized medical terminology developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
MedDRA is used internationally to classify adverse event information associated with the use of biopharmaceuticals and other medical products. It provides a consistent way to encode and analyze medical data throughout the regulatory process, from pre-marketing to post-marketing activities.
MedDRA is crucial in clinical research for ensuring consistency and accuracy in reporting adverse events and medical conditions. Its standardized terminology allows researchers and regulatory authorities to efficiently analyze safety data across different studies, pharmaceutical companies, and geographic regions.
The use of MedDRA facilitates clear communication between stakeholders in the drug development process, including sponsors, investigators, and regulatory agencies. It enhances the quality of safety signal detection and evaluation, ultimately contributing to better patient safety and more effective pharmacovigilance practices.
Clinical trials are often seen as a regulatory necessity, but for biotech and medtech startups, they can be much more.…
Axcellant participated in SNMMI’s 2025 Annual Meeting in New Orleans, where nearly 8,000 professionals in nuclear medicine and molecular imaging gathered…
Axcellant participated in the PET Symposium 2025, held in Turku, marking 50 years of PET radiochemistry at the Turku PET…
Copyright @ 2025 Axcellant